disadvantages of glp 1 Exploring the Side Effects GLP-1 Receptor Agonist: To Ensure Its Optimal Positioning SWOT analysis (Strengths, Weaknesses, Opportunities,

Clinically accessible markers like the stress-hyperglycemia ratio (SHR) further reflect this interplay between systemic metabolic disturbance and oxidative stress, offering powerful prognostic value (Lucci et al., 2025

Berberine is typically taken before or between meals, rather than with food

Key Differences Summary# Receptor pharmacology : Retatrutide targets three receptors (GIP + GLP-1 + glucagon) while survodutide targets two (GLP-1 + glucagon)

dorei , Lachnoclostridium , and Mitsuokella independently predicted glycemic response to GLP-1 RA therapy

Egger M, Davey Smith G, Schneider M, et al

The analysis on the respective cohorts was based on the following safety outcomes over 5 years from drug initiation: DKA, hypoglycaemia requiring admission to secondary care, urinary tract infection (UTI), pyelonephritis, candidiasis of the lower genital tract, acute pancreatitis and gastrointestinal upset